Neuphoria Therapeutics Inc. (NEUP) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-10-30
4:21 pm
Purchase
2023-09-2913GBIONOMICS LTD ADS
BNOX
Lynx1 Capital Management LP12,897,975
8.200%
12,897,975increase
(New Position)
Filing
History
2023-10-10
4:00 pm
Purchase
2023-09-2813GBIONOMICS LTD ADS
BNOX
TANG CAPITAL PARTNERS LP10,500,000
8.600%
10,500,000increase
(New Position)
Filing
History
2023-09-29
4:33 pm
Purchase
2023-09-2813GBIONOMICS LTD ADS
BNOX
Point72 Asset Management, L.P.9,924,390
8.100%
9,924,390increase
(New Position)
Filing
History
2022-02-14
12:56 pm
Purchase
2021-12-3113GBIONOMICS LTD ADS
BNOX
BIOTECHNOLOGY VALUE FUND L P14,174,157
13.000%
14,174,157increase
(New Position)
Filing
History
2021-12-30
4:31 pm
Purchase
2021-12-2013DNEUPHORIA THERAPEUTICS INC
NEUP
Apeiron Investment Group Ltd.33,545,866
27.700%
33,545,866increase
(New Position)
Filing
History
Goto Prev, 0, 1